Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Marcus

Showing results (361-370 of 435) with videos related to

Pageof 44
Sort By:
Theranostics|January 8, 2014
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detectionLily Yang, Hari Krishna Sajja, Zehong Cao, et al.
Cancer Research|September 5, 2006
Farnesyltransferase inhibitors reverse taxane resistanceAdam I Marcus, Aurora M O'Brate, Ruben M Buey, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2021
Corrigendum to "Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer" [Lung Cancer 123 (2018) 36-43]Fakeng Liu, Yuan Liu, Xiuju Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancerFakeng Liu, Yuan Liu, Xiuju Liu, et al.
Cancer|April 22, 2020
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16qBrian Pedro, Manali Rupji, Bhakti Dwivedi, et al.
Nature|November 28, 2019
Publisher Correction: Imaging work and dissipation in the quantum Hall state in grapheneA Marguerite, J Birkbeck, A Aharon-Steinberg, et al.
Nature|October 22, 2019
Imaging work and dissipation in the quantum Hall state in grapheneA Marguerite, J Birkbeck, A Aharon-Steinberg, et al.
Molecular Cancer Therapeutics|April 14, 2007
Farnesyl transferase inhibitors impair chromosomal maintenance in cell lines and human tumors by compromising CENP-E and CENP-F functionKatherine Schafer-Hales, Jon Iaconelli, James P Snyder, et al.
Cancer Research|May 4, 2005
The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylaseAdam I Marcus, Jun Zhou, Aurora O'Brate, et al.
Biochemistry|August 24, 2005
Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid siteMichael C Edler, Rubén M Buey, Rick Gussio, et al.
Pageof 44

Showing results (361-370 of 435) with videos related to

Sort By:
Pageof 44
Theranostics|January 8, 2014
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detectionLily Yang, Hari Krishna Sajja, Zehong Cao, et al.
Cancer Research|September 5, 2006
Farnesyltransferase inhibitors reverse taxane resistanceAdam I Marcus, Aurora M O'Brate, Ruben M Buey, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2021
Corrigendum to "Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer" [Lung Cancer 123 (2018) 36-43]Fakeng Liu, Yuan Liu, Xiuju Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2018
Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancerFakeng Liu, Yuan Liu, Xiuju Liu, et al.
Cancer|April 22, 2020
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16qBrian Pedro, Manali Rupji, Bhakti Dwivedi, et al.
Nature|November 28, 2019
Publisher Correction: Imaging work and dissipation in the quantum Hall state in grapheneA Marguerite, J Birkbeck, A Aharon-Steinberg, et al.
Nature|October 22, 2019
Imaging work and dissipation in the quantum Hall state in grapheneA Marguerite, J Birkbeck, A Aharon-Steinberg, et al.
Molecular Cancer Therapeutics|April 14, 2007
Farnesyl transferase inhibitors impair chromosomal maintenance in cell lines and human tumors by compromising CENP-E and CENP-F functionKatherine Schafer-Hales, Jon Iaconelli, James P Snyder, et al.
Cancer Research|May 4, 2005
The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylaseAdam I Marcus, Jun Zhou, Aurora O'Brate, et al.
Biochemistry|August 24, 2005
Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid siteMichael C Edler, Rubén M Buey, Rick Gussio, et al.
Pageof 44